Isaac Health has secured $10.
Author: Michael
ReviveHealth, Inc.
Immunis, Inc.
MetaVia CEO says tolerability is key to the long
Evernow has partnered with Ōura, maker of the sm
Neuronascent has published the Phase 1a clinical
Seragon Biosciences has launched Enlivien®, a no
Seraphina Therapeutics has achieved a notable ran
Omniscope launches osLongevity in pivot from imm
New summit seeks to shape the future of longevit